The challenges and clinical landscape of glioblastoma immunotherapy

The challenges and clinical landscape of glioblastoma immunotherapy

Glioblastoma is associated with a dismal prognosis with the standard of care involving surgery, radiation therapy and temozolomide chemotherapy. This review investigates the features that make glioblastoma difficult to treat and the results of glioblastoma immunotherapy clinical trials so far. There...

Full description

Bibliographic Details
Main Authors: Andrew Timothy Ng, Tyler Steve, Kevin T Jamouss, Abdul Arham, Sarah Kawtharani, Hazem I Assi
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:CNS Oncology
Subjects:
cancer vaccines
clinical research
clinical trials
drug resistance
glioblastoma
immunotherapy
Online Access:https://www.tandfonline.com/doi/10.1080/20450907.2024.2415878

Internet

https://www.tandfonline.com/doi/10.1080/20450907.2024.2415878

Similar Items